Two Vaccines for Staphylococcus aureus Induce a B-Cell- Mediated Immune Response
Staphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel S. aureus vaccine (SA4Ag) is in development, targeting the capsular polysaccharides (CPs) and two virulence-associated surface proteins. Vaccine-elicited antibody responses to CPs are efficacious agai...
| Main Authors: | , , , , , , , , |
|---|---|
| 其他作者: | |
| 格式: | 文件 |
| 出版: |
American Society for Microbiology
2019
|
| 在线阅读: | http://hdl.handle.net/1721.1/121102 https://orcid.org/0000-0002-4501-4516 https://orcid.org/0000-0003-0274-9392 https://orcid.org/0000-0003-0921-3144 |